Several studies have reported higher serum sclerostin level in chronic kidney disease (CKD) patients with cardiovascular events [34], such as coronary [35] and aortic calcification [36] and the effect of sclerostin levels on CVD and all-cause cardiovascular mortality in patients with CKD [16, 37]. Here, SOST is linked to chronic kidney disease.